H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and health and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for tile setting, commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.

H. B. Fuller Company

Fulcrum Lithium Ltd. ( ($AU:FUL) ) has shared an update. Fulcrum Lithium has reported its thickest and highest-grade lithium mineralisation to date...

Fulcrum Lithium hits thick, high-grade lithium in Nevada as Alkali Flats resource nears

Fulton Financial (($FULT)) has held its Q1 earnings call. Read on for the main highlights of the call. Fulton Financial’s latest earnings call stru...

Fulton Financial Signals Steady Path After Earnings Call

In a report released on May 8, Tazeen Ahmad from Bank of America Securities reiterated a Sell rating on Fulcrum Therapeutics, with a price target o...

Bank of America Securities Keeps Their Sell Rating on Fulcrum Therapeutics (FULC)

Fulton Financial ( ($FULT) ) has shared an update. On May 5, 2026, Fulton Financial Corporation completed a $300 million underwritten public offeri...

Fulton Financial Completes Subordinated Notes Offering for Refinancing

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Fulcrum Therapeutics (FULC) and Sanofi (SNYNF) with ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FUL	$57.78	+2.50%	1.68M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FUL	$57.78	+2.5%	1.68M
3
4
5
6

FUL

FUL

Get H. B. Fuller Company Data in Excel

Get H. B. Fuller Company Data in Excel